High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer Recruiting Phase 2 Trials for Azenosertib (DB18028)

IndicationStatusPhase
DBCOND0161887 (High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05128825A Study of ZN-c3 in Subjects With High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal CancerTreatment